Navigation Links
Alliance, Inc. Receives Centers of Excellence in Recovery Grant
Date:3/2/2010

BALTIMORE, March 2 /PRNewswire-USNewswire/ -- Alliance, Inc., a non-profit community-based provider of mental health treatment and rehabilitation services in the Baltimore area, has been selected as one of four agencies in Maryland to receive a Centers of Excellence in Recovery grant through the Howard County Mental Health Authority. The concept of recovery in mental health is rooted in the firm conviction that individuals with mental illness can and do recover.

Under the terms of the award, Alliance receives a one-time payment of $10,000, training, and ongoing technical assistance throughout 2010 in the recovery model of care from nationally-recognized experts. As a result of its participation, Alliance will foster an agency-wide culture of recovery and in turn, will disseminate this training to other service providers. Alliance officially launched the program last month at its Belcamp office in Harford County, Md.  

"We are so delighted to be selected to receive this award," said Philip Taff, chief executive officer for Alliance. "To be chosen as one of four agencies in the state to receive this grant is truly an honor and we are proud to be recognized for our commitment to empowering individuals with mental illness to live life to the fullest."

The Centers for Excellence in Recovery program is made possible through funding received from the federal Substance Abuse and Mental Health Services Administration's (SAMHSA) Mental Health Transformation Grant. The program is the result of collaboration among many mental health advocates including the Maryland Association of Core Service Agencies, the Mental Hygiene Administration, On Our Own of Maryland, Inc., and the University of Maryland Evidence-Based Practice Center. It is part of a coordinated effort to ensure that theory meets practice in the daily delivery of mental health services through the public mental health system.

Alliance, Inc., a private, non-profit 501 (c)(3) organization, provides community-based services to individuals with disabilities. With headquarters in Dundalk, Md. and locations throughout central Maryland, Alliance has served the Baltimore community for more than 25 years. Alliance has received the highest level of accreditation from the Commission for Accreditation of Rehabilitation Facilities (CARF) for seven consecutive three-year terms, demonstrating its consistent conformance to the highest industry standards possible among community-based mental health providers.

SOURCE Alliance, Inc.

Back to top
'/>"/>
SOURCE Alliance, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Doctor Mortgage Alliance, The National Real Estate Referral Firm That Specializes In Finding Real Estate Loans, Has Just Expanded Their Services
2. Statement by Dr. Paul Zeitz, Executive Director, Global AIDS Alliance, Washington, DC on President Obamas Global Health Funding for FY10 as Released by the White House Tuesday, May 5, 2009
3. Leading Independent Proxy Advisory Firm Supports Specialty Underwriters Alliance, Inc. in Its Proxy Contest Against Hallmark Financial Services, Inc.
4. Specialty Underwriters Alliance, Inc. Announces Fourth Quarter and Year End 2008 Conference Call
5. New Coalition, the Eldercare Workforce Alliance, to Address the Critical Shortage of Healthcare Workers Capable of Meeting the Unique Care Needs of Older Adults
6. News from CA: Cancer Quality Alliance, blueprint for a better cancer care system
7. Stop Obesity Alliance, Chair Dr. Richard H. Carmona, National Opinion Research Center Reveal Findings of Survey Showing Employer Concern About Health, Financial Costs of Obesity
8. Cepheid Signs Group Purchasing Contract With Premier Healthcare Alliance, One of the Largest U.S. Group Purchasing Organizations
9. Specialty Underwriters Alliance, Inc. Reports 2007 Fourth Quarter and Full Year Results
10. Backus Receives Top Martindale Hubbell Rating
11. GateWay Community College Receives Strong Endorsement for Re-accreditation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: